Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-07-06 13:18 UTC

Splash Beverage Acquires Exclusive Global Rights for Epilepsy Therapy CannEpil

() -- Splash Beverage (SBEV) said Monday it has signed an agreement with Argent BioPharma to acquire exclusive global licensing for an initial 20-year term for CannEpil, a cannabinoid-based investigational therapeutic for the treatment of drug-resistant epilepsy. As part of the deal, Splash has secured a $1 million com

SBEV

News 2026-07-06 12:31 UTC

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engag

FORT LAUDERDALE, Fla., July 06, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE A

FDA FORT GLOBE RGT RGT.AX SBEV U.S

Search market news

Matching instruments

Splash Beverage Acquires Exclusive Global Rights for Epilepsy Therapy CannEpil

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engag